NCT03932669View on ClinicalTrials.gov

Effect of Nilotinib in Cerebellar Ataxia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

August 13, 2020

Study Completion Date

August 13, 2020

Conditions
Ataxia, CerebellarAtaxia, Progressive
Interventions
DRUG

Nilotinib

150-300mg daily dose of nilotinib

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03932669 - Effect of Nilotinib in Cerebellar Ataxia Patients | Biotech Hunter | Biotech Hunter